SATG logo

SATG
Leverage Shares 2x Long SATS Daily ETF

40
Volume
1.18M
52W High
$24.99
52W Low
$13.48
50D MA
$18.14
Prev Close
$18.91
Loading...
Loading...
News
all
press releases
News Placeholder
Bernstein upgrades Sartorius to “outperform” on margin recovery, pharma demand
News Placeholder
RBC upgrades Sartorius stocks as recent pullback ’provides entry opportunity’ 
News Placeholder
Sartorius AG and its biotech subsidiary lifted to Buy at Barclays
Investing.com -- Barclays has upgraded Sartorius AG (F:SATG) and its subsidiary Sartorius Stedim (EPA:STDM) Biotech SA (VIE:DIM) to Overweight, citing a shift in the bioprocessing industry toward a post-COVID recovery.
News Placeholder
Sartorius shares soar 11% on strong Q4, order intake drives rally
<
...
1
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available